✦ LIBER ✦

The pharmacokinetics of cefotaxime and ceftriaxone in renal and hepatic dysfunction

✍ Scribed by R. Wise; N. Wright

Publisher: Springer-Verlag
Year: 1985
Tongue: English
Weight: 851 KB
Volume: 13
Category: Article
ISSN: 0300-8126
DOI: 10.1007/bf01644237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The pharmacokinetics of ceftriaxone and

The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites

✍ L. Hary; M. Andrejak; S. Leleu; J. Orfila; J. P. Capron 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 462 KB

Pharmacokinetics of tocainide in patient

Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction

✍ D. Oltmanns; A. Pottage; W. Endell 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 536 KB

A comparison of the pharmacokinetics and

A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime

✍ Wise, R. ;Andrews, J. M. 📂 Article 📅 1983 🏛 Springer-Verlag ⚖ 229 KB

Pharmacokinetics of amiloride in renal a

Pharmacokinetics of amiloride in renal and hepatic disease

✍ H. Spahn; K. Reuter; E. Mutschler; W. Gerok; H. Knauf 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 622 KB

Pharmacokinetics and safety of ceftriaxo

Pharmacokinetics and safety of ceftriaxone in the neonate

✍ A. Mulhall; J. Louvois; J. James 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 386 KB

The pharmacokinetics and safety of ceftriaxone were examined in 39 neonates who required antibiotics for clinically suspected sepsis. The drug was administered as a once daily dose of 50 mg/kg by the intravenous (IV) or intramuscular (IM) route. Ceftriaxone was assayed in 49 series of blood samples,

Pharmacokinetics, safety, and tolerabili

Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction

✍ J. L. Hinson; I. D. Hind; D. J. Weidler 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB